Otonomy, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“Administration of OTO-104 in sheep is associated with lasting exposure in the perilymph (> 3 weeks).” (Page 1) Read the full document
Otonomy, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The firm’s portfolio includes therapeutics for diseases and disorders of the ear such as otitis media, acute otitis externa, balance disorders, Ménière’s disease, tinnitus, cisplatin-induced hearing loss, and sensorineural hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan in April 2008 and is headquartered in San Diego, CA. [Source: MarketWatch]
Company Website: http://www.otonomy.com